These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21612875)

  • 21. Quantitative molecular monitoring of residual tumor cells in chronic lymphocytic leukemia.
    Pfitzner T; Reiser M; Barth S; Borchmann P; Schulz H; Schinköthe T; Oberhäuser F; Wessels J; Tur M; Diehl V; Engert A
    Ann Hematol; 2002 May; 81(5):258-66. PubMed ID: 12029535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of disseminated tumor cells: strategies and diagnostic implications.
    Zehentner BK
    Expert Rev Mol Diagn; 2002 Jan; 2(1):41-8. PubMed ID: 11963801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer stem cells in solid tumors.
    Er O
    Onkologie; 2009 Oct; 32(10):605-9. PubMed ID: 19816080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Premetastatic niches, exosomes and circulating tumor cells: Early mechanisms of tumor dissemination and the relation to surgery.
    Raskov H; Orhan A; Salanti A; Gögenur I
    Int J Cancer; 2020 Jun; 146(12):3244-3255. PubMed ID: 31808150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer stem cells: an old idea--a paradigm shift.
    Wicha MS; Liu S; Dontu G
    Cancer Res; 2006 Feb; 66(4):1883-90; discussion 1895-6. PubMed ID: 16488983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic impact of bone marrow micrometastases in women with breast cancer.
    Braun S; Auer D; Marth C
    Cancer Invest; 2009 Jul; 27(6):598-603. PubMed ID: 19557580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functions of tumorigenic and migrating cancer progenitor cells in cancer progression and metastasis and their therapeutic implications.
    Mimeault M; Batra SK
    Cancer Metastasis Rev; 2007 Mar; 26(1):203-14. PubMed ID: 17273942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Researchers exploring implications of minimal residual cancer.
    McBride G
    J Natl Cancer Inst; 2005 Nov; 97(22):1642-3. PubMed ID: 16288116
    [No Abstract]   [Full Text] [Related]  

  • 29. Current status in human breast cancer micrometastasis.
    Alix-Panabières C; Müller V; Pantel K
    Curr Opin Oncol; 2007 Nov; 19(6):558-63. PubMed ID: 17906452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Minimal residual disease in breast cancer: detection and clinical relevance].
    Pantel K; Wölfle U
    Verh Dtsch Ges Pathol; 2005; 89():68-75. PubMed ID: 18035675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Direct molecular analysis of single disseminated cancer cells: a prerequisite for the development of adjuvant therapies?].
    Klein CA
    Acta Med Austriaca Suppl; 2002; 59():10-3. PubMed ID: 12506754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical significance of circulating tumor cells in the peripheral blood.
    Elshimali YI; Grody WW
    Diagn Mol Pathol; 2006 Dec; 15(4):187-94. PubMed ID: 17122646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?
    Goss P; Allan AL; Rodenhiser DI; Foster PJ; Chambers AF
    APMIS; 2008; 116(7-8):552-68. PubMed ID: 18834402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimal residual disease in cancer therapy--Small things make all the difference.
    Blatter S; Rottenberg S
    Drug Resist Updat; 2015; 21-22():1-10. PubMed ID: 26307504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
    Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
    Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The hydra phenomenon of cancer: why tumors recur locally after microscopically complete resection.
    Höckel M; Dornhöfer N
    Cancer Res; 2005 Apr; 65(8):2997-3002. PubMed ID: 15833823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful therapy must eradicate cancer stem cells.
    Dingli D; Michor F
    Stem Cells; 2006 Dec; 24(12):2603-10. PubMed ID: 16931775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating tumour cells in breast cancer--review.
    Vertakova KB; Sanislo L; Spanik S; Svec J; Ondrus D
    Klin Onkol; 2010; 23(2):86-91. PubMed ID: 20465086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer stem cells in solid tumors: is 'evading apoptosis' a hallmark of cancer?
    Enderling H; Hahnfeldt P
    Prog Biophys Mol Biol; 2011 Aug; 106(2):391-9. PubMed ID: 21473880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.